(AVNM) American Century Trust - Overview
Etf: Equity, ETF, Diversified, Fund-Of-Funds
Dividends
| Dividend Yield | 2.98% |
| Yield on Cost 5y | 4.38% |
| Yield CAGR 5y | 49.60% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.9% |
| Relative Tail Risk | 2.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.30 |
| Alpha | 34.85 |
| Character TTM | |
|---|---|
| Beta | 0.635 |
| Beta Downside | 0.611 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.03% |
| CAGR/Max DD | 1.71 |
Description: AVNM American Century Trust December 31, 2025
The AVNM fund operates as a “fund of funds,” allocating its capital to a suite of Avantis-managed ETFs rather than holding individual stocks directly. This structure lets AVNM inherit the diversified equity exposure of its underlying ETFs, which aim to overweight securities with superior expected returns or risk-adjusted profiles relative to a traditional market-cap index.
Key quantitative details (as of Q3 2024) include an expense ratio of 0.12 %, total assets under management of roughly $850 million, and a top-10 holding concentration of about 15 %-primarily large-cap firms in the U.S., Europe, and Japan. The fund’s turnover rate sits near 30 % annually, reflecting the active rebalancing of its underlying ETFs.
Performance drivers are tied to global macro trends: (1) sustained earnings growth in developed-market large caps, (2) relative strength of the U.S. dollar versus other major currencies, which can affect foreign-currency-hedged returns, and (3) central-bank policy divergence that influences equity risk premiums across regions. A slowdown in any of these factors could weigh on the fund’s upside potential.
If you’re looking to deepen your analysis, a quick check on ValueRay’s platform can surface comparable peer metrics and scenario simulations for AVNM.
What is the price of AVNM shares?
Over the past week, the price has changed by +3.59%, over one month by +7.38%, over three months by +14.11% and over the past year by +46.21%.
Is AVNM a buy, sell or hold?
What are the forecasts/targets for the AVNM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 99.3 | 22.4% |
AVNM Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 523.0m USD (523.0m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 523.0m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 523.0m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.26% (E(523.0m)/V(523.0m) * Re(8.26%) + (debt-free company))
Discount Rate = 8.26% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)